Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protein-protein interaction modulators: advances, successes and remaining challenges
Lloyd Mabonga, Abidemi Paul Kappo
Biophysical Reviews (2019) Vol. 11, Iss. 4, pp. 559-581
Open Access | Times Cited: 175

Showing 1-25 of 175 citing articles:

Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Lei Zhong, Yueshan Li, Liang Xiong, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1176
Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site
Jaeyong Lee, L.J. Worrall, M. Vuckovic, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 212
Receptor for Advanced Glycation End Products (RAGE) and Mechanisms and Therapeutic Opportunities in Diabetes and Cardiovascular Disease: Insights From Human Subjects and Animal Models
Lander Egaña-Gorroño, Raquel López‐Díez, Gautham Yepuri, et al.
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 174
Genome mining methods to discover bioactive natural products
Katherine D. Bauman, Keelie S. Butler, Bradley S. Moore, et al.
Natural Product Reports (2021) Vol. 38, Iss. 11, pp. 2100-2129
Open Access | Times Cited: 121
Molecular Glue Discovery: Current and Future Approaches
Jeffrey A. Dewey, Clémence Delalande, Saara‐Anne Azizi, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9278-9296
Open Access | Times Cited: 53
Targeting Tau Protein with Proximity Inducing Modulators: A New Frontier to Combat Tauopathies
Elisa Uliassi, María Laura Bolognesi, Andrea Milelli
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 3, pp. 654-672
Closed Access | Times Cited: 3
NMR as a “Gold Standard” Method in Drug Design and Discovery
Abdul‐Hamid Emwas, Kacper Szczepski, Benjamin Gabriel Poulson, et al.
Molecules (2020) Vol. 25, Iss. 20, pp. 4597-4597
Open Access | Times Cited: 86
The design and development of covalent protein-protein interaction inhibitors for cancer treatment
Shasha Cheng, Guan‐Jun Yang, Wanhe Wang, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 82
Glycogen Synthase Kinase 3β: A New Gold Rush in Anti-Alzheimer’s Disease Multitarget Drug Discovery?
Angela De Simone, Vincenzo Tumiatti, Vincenza Andrisano, et al.
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 1, pp. 26-41
Open Access | Times Cited: 72
Computational design of novel protein–protein interactions – An overview on methodological approaches and applications
Anthony Marchand, Alexandra Van Hall‐Beauvais, Bruno E. Correia
Current Opinion in Structural Biology (2022) Vol. 74, pp. 102370-102370
Open Access | Times Cited: 54
De novo molecular design with deep molecular generative models for PPI inhibitors
Jianmin Wang, Yanyi Chu, Jiashun Mao, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 4
Closed Access | Times Cited: 48
Single-molecule fingerprinting of protein-drug interaction using a funneled biological nanopore
Ki‐Baek Jeong, Minju Ryu, Jinsik Kim, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Fragment-based drug discovery supports drugging ‘undruggable’ protein–protein interactions
Zhi-Zheng Wang, Xing-Xing Shi, Guang-Yi Huang, et al.
Trends in Biochemical Sciences (2023) Vol. 48, Iss. 6, pp. 539-552
Closed Access | Times Cited: 27
New insights into protein–protein interaction modulators in drug discovery and therapeutic advance
Hossam Nada, Yongseok Choi, Sung-Do Kim, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Structure-based discovery of hydrocarbon-stapled paxillin peptides that block FAK scaffolding in cancer
Lauren Reyes, Lisa Naser, Warren S. Weiner, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
The Potential of Peptide-Based Inhibitors in Disrupting Protein–Protein Interactions for Targeted Cancer Therapy
Ana Maria Sardinha Afonso, Carlos Cavaleiro, Miguel A. R. B. Castanho, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3117-3117
Open Access | Times Cited: 1
Immobilization of l-asparaginase on gold nanoparticles for novel drug delivery approach as anti-cancer agent against human breast carcinoma cells
Ali G. Al-Dulimi, Ali Z. Al‐Saffar, Ghassan M. Sulaiman, et al.
Journal of Materials Research and Technology (2020) Vol. 9, Iss. 6, pp. 15394-15411
Open Access | Times Cited: 63
Enhanced Suppression of a Protein–Protein Interaction in Cells Using Small-Molecule Covalent Inhibitors Based on an N-Acyl-N-alkyl Sulfonamide Warhead
Tsuyoshi Ueda, Tomonori Tamura, Masaharu Kawano, et al.
Journal of the American Chemical Society (2021) Vol. 143, Iss. 12, pp. 4766-4774
Open Access | Times Cited: 56
<p>Current Challenges and Opportunities in Designing Protein–Protein Interaction Targeted Drugs</p>
Woong‐Hee Shin, Keiko Kumazawa, Kenichiro Imai, et al.
Advances and Applications in Bioinformatics and Chemistry (2020) Vol. Volume 13, pp. 11-25
Open Access | Times Cited: 54
Pathways to Parkinson’s disease: a spotlight on 14-3-3 proteins
Elena Giusto, Talene A. Yacoubian, Elisa Greggio, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 42
Emerging landscape of molecular interaction networks: Opportunities, challenges and prospects
Gauri Panditrao, Rupa Bhowmick, Chandrakala Meena, et al.
Journal of Biosciences (2022) Vol. 47, Iss. 2
Open Access | Times Cited: 30
Understanding the function and regulation of Sox2 for its therapeutic potential in breast cancer
Ankita Dey, Moumita Kundu, Subhayan Das, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 2, pp. 188692-188692
Closed Access | Times Cited: 29
Molecular glues modulate protein functions by inducing protein aggregation: A promising therapeutic strategy of small molecules for disease treatment
Hongyu Wu, Hong Yao, Chen He, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 9, pp. 3548-3566
Open Access | Times Cited: 29
Towards design of drugs and delivery systems with the Martini coarse-grained model
Lisbeth R. Kjølbye, Gilberto P. Pereira, Alessio Bartocci, et al.
QRB Discovery (2022) Vol. 3
Open Access | Times Cited: 29
Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence
Miquel Duran‐Frigola, Marko Cigler, Georg E. Winter
Journal of the American Chemical Society (2023) Vol. 145, Iss. 5, pp. 2711-2732
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top